Andrea Gerardo Antonio L.
- Country
- Italy
- Department
- Department of Biomedical Sciences
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Evaluation of CRN04894 Safety, Efficacy, and Pharmacokinetics in Congenital Adrenal Hyperplasia: A 12-Week, Phase 2 Open-Label, Sequential Dose Cohort Study
- A Phase 2b Randomized Study of IMVT-1402 Versus Placebo in Adult Patients with Graves' Disease
Data & Insights
Has run more than one trial at 72 of 119 partner sites.
Specializations
Endocrine Disorders
The investigator specializes in studying Congenital Adrenal Hyperplasia (CAH), focusing on innovative therapeutic approaches for managing this inherited endocrine condition.
- Adrenal Function
- Steroid Metabolism
- Endocrine System Disorders
Their research interests include hormonal regulation and metabolic pathways associated with adrenal disorders.
Therapeutic Development
This investigator conducts research in novel therapeutic interventions for endocrine disorders, with particular attention to treatment safety and efficacy assessment.
- Treatment Safety Evaluation
- Drug Tolerability Studies
- Pharmacokinetic Analysis
Their work encompasses the evaluation of biochemical markers including androstenedione levels in therapeutic responses.
Clinical Assessment
The investigator focuses on comprehensive clinical evaluation methods in inherited metabolic disorders, particularly those affecting hormone production.
- Biomarker Analysis
- Treatment Response Monitoring
- Clinical Outcomes Assessment
Their expertise includes measuring and analyzing hormonal parameters in endocrine conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.